Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triple Combination Therapy (Bimatoprost/Brimonidine/Timolol) in Glaucoma or Ocular Hypertension
NCT01217606Phase 3Completed
- Sponsor
- Allergan
- Start
- Jan 2011
- Primary completion
- Sep 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of bimatoprost in primary open-angle glaucoma (POAG), ocular hypertension, sponsored by Allergan. Started Jan 2011; status: completed.
02
Drugs
bimatoprost
03
Conditions
primary open-angle glaucoma (POAG)ocular hypertension
Beyond the preview
Go deeper on NCT01217606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01217606.